drugset / Trial / NCT04217291
The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study in patients with type 2 diabetes mellitus (T2DM).
Timeline
- Start
- 2019-12-10
- Primary completion
- 2021-07-09
- Completion
- 2021-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2608204 | Small molecule | 80 mg | Oral |
| Subject | LY2608204 | Small molecule | 160 mg | Oral |
| Subject | LY2608204 | Small molecule | 240 mg | Oral |